Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06004375
Status:
COMPLETED
Last Update Posted:
2023-08-22
First Post:
2023-08-19
Brief Title:
THE EFFECT OF ARGININE AND GLUTAMINE ON COVID-19 PATIENTS OUTCOME A RANDOMIZED CLINICAL TRIAL
Sponsor:
Universitas Sriwijaya
Organization:
Universitas Sriwijaya
Study Overview
Official Title:
THE EFFECT OF ARGININE AND GLUTAMINE ON COVID-19 PATIENTS OUTCOME A RANDOMIZED CLINICAL TRIAL
Status:
COMPLETED
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to determine effect of arginine and glutamine on outcome of COVID-19 patients The main questions it aims to answer are
-to test the effect of oral nutritional supplements containing arginine and glutamine on covid-19 patients outcome Dr M Djamil General Hospital Padang
Participants will given ONS containing arginine and glutamine Researchers will compare intervention group with control group to see if ONS affected outcome of COVID-19 patients
-to test the effect of oral nutritional supplements containing arginine and glutamine on covid-19 patients outcome Dr M Djamil General Hospital Padang
Participants will given ONS containing arginine and glutamine Researchers will compare intervention group with control group to see if ONS affected outcome of COVID-19 patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None